Anthony Cataldo of Oxis Biotech touts immunotherapies targeting lymphoma and leukemia.
latest articles
Is this harmony in health care?
Some lodging businesses remain confident that tourism numbers will remain strong through the fall.
The company hopes the semantic coding specialist will help push its electronic health records system to market in other countries.
Construction on the six-block research, education, commercial and product development space is set to start in late 2017.
There are now legal commitments to pay for the local share of the $1.858 billion project. But in keeping with so much of the process surrounding the planning of Southwest LRT, it wasn’t easy.
The final eight companies will move on for the chance to win $50,000 in seed capital.
Some tips for managing those annual forays into strategy and vision.
The best opportunities for networking this month.
Incubator aims to help Mitchell Hamline School of Law grads launch firms that charge affordable rates.
The Minnesota High Tech Association, state government and private companies are providing hundreds of paid internships to increase the high tech workforce.
The new federal trade secrets law has major ramifications for intellectual property and employment disputes.
The school claimed Gilead Sciences used a drug it developed to create and heavily profit off of Hepatitis C medications.
Medical properties are seen as solid investments.
New report adds to evidence that employees are paying more for their own care.
Diagnostic kit-maker DiaSorin tapped by U.S. to roll out test, process results.